Ignite Creation Date:
2025-12-25 @ 3:18 AM
Ignite Modification Date:
2026-02-22 @ 2:13 AM
Study NCT ID:
NCT02202005
Status:
COMPLETED
Last Update Posted:
2015-08-25
First Post:
2014-07-24
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Multiple Dose BE Study With Nevirapine 400mg PR Tablets
Sponsor:
Ratiopharm GmbH
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
NEVIR5U14EU
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None